The Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Aim 2 of RDCRN (Rare Diseases Clinical Research Network) Project 2
Latest Information Update: 16 Dec 2024
Price :
$35 *
At a glance
- Drugs Droxidopa (Primary) ; Midodrine (Primary)
- Indications Autonomic-nervous-system-disorders; Multiple system atrophy; Orthostatic hypotension; Parkinson's disease
- Focus Therapeutic Use
- 12 Dec 2024 Planned End Date changed from 1 Dec 2024 to 1 Dec 2025.
- 12 Dec 2024 Planned primary completion date changed from 1 Sep 2024 to 1 Sep 2025.
- 28 Mar 2024 Planned End Date changed from 1 Aug 2024 to 1 Dec 2024.